These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9015389)
1. Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs. Nodland KI; Wormke M; Safe S Arch Biochem Biophys; 1997 Feb; 338(1):67-72. PubMed ID: 9015389 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Krishnan V; Porter W; Santostefano M; Wang X; Safe S Mol Cell Biol; 1995 Dec; 15(12):6710-9. PubMed ID: 8524236 [TBL] [Abstract][Full Text] [Related]
3. Estrogen does not inhibit 2,3,7, 8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. Hoivik D; Willett K; Wilson C; Safe S J Biol Chem; 1997 Nov; 272(48):30270-4. PubMed ID: 9374512 [TBL] [Abstract][Full Text] [Related]
4. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Zacharewski TR; Bondy KL; McDonell P; Wu ZF Cancer Res; 1994 May; 54(10):2707-13. PubMed ID: 8168101 [TBL] [Abstract][Full Text] [Related]
5. Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells. Hoivik D; Wilson C; Wang W; Willett K; Barhoumi R; Burghardt R; Safe S Arch Biochem Biophys; 1997 Dec; 348(1):174-82. PubMed ID: 9390189 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Duan R; Porter W; Samudio I; Vyhlidal C; Kladde M; Safe S Mol Endocrinol; 1999 Sep; 13(9):1511-21. PubMed ID: 10478842 [TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct. Merchant M; Safe S Biochem Pharmacol; 1995 Aug; 50(5):663-8. PubMed ID: 7669069 [TBL] [Abstract][Full Text] [Related]
8. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells. Wormke M; Castro-Rivera E; Chen I; Safe S J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa 1c1c7 cells. Zacharewski T; Harris M; Safe S Biochem Pharmacol; 1991 Jun; 41(12):1931-9. PubMed ID: 1645554 [TBL] [Abstract][Full Text] [Related]
10. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. Liu H; Wormke M; Safe SH; Bjeldanes LF J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413 [TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045 [TBL] [Abstract][Full Text] [Related]
12. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Merchant M; Krishnan V; Safe S Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116 [TBL] [Abstract][Full Text] [Related]
15. Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Thomsen JS; Wang X; Hines RN; Safe S Carcinogenesis; 1994 May; 15(5):933-7. PubMed ID: 8200098 [TBL] [Abstract][Full Text] [Related]
16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action. Safe S; Astroff B; Harris M; Zacharewski T; Dickerson R; Romkes M; Biegel L Pharmacol Toxicol; 1991 Dec; 69(6):400-9. PubMed ID: 1766914 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Harper N; Wang X; Liu H; Safe S Mol Cell Endocrinol; 1994 Aug; 104(1):47-55. PubMed ID: 7821706 [TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Duan R; Porter W; Safe S Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate. Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on MCF-7, RL95-2, and LNCaP cells: role of target steroid hormones in cellular responsiveness to CYP1A1 induction. Jana NR; Sarkar S; Ishizuka M; Yonemoto J; Tohyama C; Sone H Mol Cell Biol Res Commun; 2000 Sep; 4(3):174-80. PubMed ID: 11281733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]